Odelia Muller

1.3k total citations
14 papers, 366 citations indexed

About

Odelia Muller is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Odelia Muller has authored 14 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Odelia Muller's work include Tuberculosis Research and Epidemiology (7 papers), Pneumonia and Respiratory Infections (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Odelia Muller is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Pneumonia and Respiratory Infections (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Odelia Muller collaborates with scholars based in South Africa, Germany and Switzerland. Odelia Muller's co-authors include Helen Cox, Virginia De Azevedo, John Simpson, Mark P. Nicol, Gilles Van Cutsem, Johnny Daniels, Jennifer Hughes, Vivian Cox, Widaad Zemanay and Andrew Whitelaw and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and PLoS Medicine.

In The Last Decade

Odelia Muller

13 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Odelia Muller South Africa 9 280 258 92 28 21 14 366
Dubravka Salemović Serbia 10 191 0.7× 179 0.7× 93 1.0× 5 0.2× 22 1.0× 41 379
Junior Mutsvangwa Zimbabwe 9 240 0.9× 189 0.7× 82 0.9× 16 0.6× 16 0.8× 25 316
Andrei Mosneaga United States 4 292 1.0× 151 0.6× 41 0.4× 22 0.8× 18 0.9× 5 359
SIMONE S. JEAN United States 7 372 1.3× 268 1.0× 125 1.4× 18 0.6× 13 0.6× 7 483
Richard Brindle United Kingdom 7 260 0.9× 242 0.9× 98 1.1× 32 1.1× 22 1.0× 8 336
Nkeko Tshabangu United States 8 184 0.7× 201 0.8× 101 1.1× 13 0.5× 21 1.0× 10 334
Maria Leide Wand-Del-Rey de Oliveira Brazil 14 536 1.9× 251 1.0× 166 1.8× 5 0.2× 39 1.9× 34 592
S Žerjav Serbia 11 144 0.5× 206 0.8× 82 0.9× 4 0.1× 22 1.0× 28 350
Kobus Venter South Africa 5 245 0.9× 175 0.7× 56 0.6× 11 0.4× 13 0.6× 10 320
Niclas Winqvist Sweden 12 293 1.0× 249 1.0× 148 1.6× 7 0.3× 17 0.8× 26 379

Countries citing papers authored by Odelia Muller

Since Specialization
Citations

This map shows the geographic impact of Odelia Muller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odelia Muller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odelia Muller more than expected).

Fields of papers citing papers by Odelia Muller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odelia Muller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odelia Muller. The network helps show where Odelia Muller may publish in the future.

Co-authorship network of co-authors of Odelia Muller

This figure shows the co-authorship network connecting the top 25 collaborators of Odelia Muller. A scholar is included among the top collaborators of Odelia Muller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odelia Muller. Odelia Muller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mohr-Holland, Erika, Johnny Daniels, Petros Isaakidis, et al.. (2017). DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLoS ONE. 12(5). e0178054–e0178054. 11 indexed citations
2.
Mohr-Holland, Erika, Johnny Daniels, Odelia Muller, et al.. (2017). Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. The International Journal of Tuberculosis and Lung Disease. 21(10). 1100–1105. 6 indexed citations
3.
Mohr-Holland, Erika, Vivian Cox, Lynne Wilkinson, et al.. (2015). Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 109(7). 425–432. 18 indexed citations
4.
Cox, Helen, Johnny Daniels, Odelia Muller, et al.. (2015). Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa. Open Forum Infectious Diseases. 2(1). ofv014–ofv014. 59 indexed citations
5.
Cox, Helen, Andrew Whitelaw, Odelia Muller, et al.. (2014). Impact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial. PLoS Medicine. 11(11). e1001760–e1001760. 116 indexed citations
6.
Moyo, Sizulu, Jennifer Furin, Jennifer Hughes, et al.. (2014). Outcomes in Adolescents Undergoing Treatment for Drug-resistant Tuberculosis in Cape Town, South Africa, 2008-2013. Archives of Pediatric Infectious Diseases. 2(2). 18 indexed citations
7.
Kaiser, Gernot, Matthias Heuer, Odelia Muller, et al.. (2010). Organspendeprozess an einem Krankenhaus mit Maximalversorgung. DMW - Deutsche Medizinische Wochenschrift. 135(42). 2065–2070. 8 indexed citations
8.
Cox, Helen, Virginia De Azevedo, Odelia Muller, et al.. (2010). Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa. PLoS ONE. 5(11). e13901–e13901. 75 indexed citations
9.
Vogel, Friedrich, Bilal Al‐Nawas, Michael Kresken, et al.. (2002). [Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy].. PubMed. 25(6). 193–204. 16 indexed citations
10.
Frey, Norbert, et al.. (1995). [A transgenic animal model: new possibilities for cardiovascular research].. PubMed. 84 Suppl 4. 17–32. 3 indexed citations
11.
Muller, Odelia. (1993). [AIDS in Thailand--features of the epidemic in an Asian country with high incidence of HIV infection].. PubMed. 8(11). 583–92. 1 indexed citations
12.
Daicker, B., Léonidas Zografos, & Odelia Muller. (1988). Homolaterale episklerale Metastase oder chirurgische Aussaat eines Proton-bestrahlten Ziliarkörpermelanoms?. Klinische Monatsblätter für Augenheilkunde. 192(5). 579–581.
13.
Fabricius, Katrine, et al.. (1980). [Critical study on methods for determining antibiotic tissue levels in humans (author's transl)].. PubMed. 30(1). 1–5. 5 indexed citations
14.
Sundmacher, R., et al.. (1976). Interferon in Treatment of Dendritic Keratitis in Humans: A Preliminary Report. The Journal of Infectious Diseases. 133(Supplement 2). A160–A164. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026